Search
Search Constraints
You searched for: Author/Creator Lernoux, ManonLimit your search
- Lernoux, Manon [remove] 2
- 615.105 2
- Médicaments -- Recherche -- Périodiques 2
- Pharmacologie -- Périodiques 2
- Pharmacology -- Periodicals 2
- Research -- Periodicals 2
- 4-HB 4-hydroxybenzoic acid -- ABL Abelson -- ALDH aldehyde dehydrogenase -- BCR breakpoint cluster region -- BID BH3 interacting-domain death agonist -- CD cluster of differentiation -- CI combination index -- CML chronic myeloid leukemia -- CPX cyclophosphamide -- CrkL Crk-like protein -- FBS fetal bovine serum -- FITC fluorescein isothiocyanate -- HDAC histone deacetylase -- HDACi histone deacetylase inhibitor -- HSP heat shock protein -- KBM-5R imatinib-resistant KBM-5 -- K-562R imatinib-resistant K-562 -- LSC leukemia stem cell -- Mcl-1 myeloid cell leukemia 1 -- MPER mammalian protein extraction reagent -- MTT 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide -- PARP poly(ADP-ribose) polymerase -- PBMC peripheral blood mononuclear cell -- PBS phosphate-buffered saline -- PDB protein data bank -- PHA phytohemagglutinin -- SAHA suberanilohydroxamic acid -- siRNA small interfering RNA -- STAT5 phosphorylated signal transducer and activator of transcription 5 -- TKI tyrosine kinase inhibitor -- VP-16 etoposide -- Z-VAD-FMK zVAD 1
- 4-hydroxybenzoic acid -- Tyrosine kinase inhibitor -- Combination chemotherapy -- Synergistic cytotoxic effect -- Imatinib resistance -- Leukemia stem cells 1
- ALL acute lymphoblastic leukemia -- AML acute myeloid leukemia -- AP activator protein -- AR androgen receptor -- BAX Bcl-2-associated X protein -- Bcl B-cell lymphoma -- BUZ ubiquitin-binding domain -- CDK cyclin-dependent kinase -- CLIP cytoplasmic linker protein -- CLL chronic lymphocytic leukemia -- CTCL cutaneous T-cell lymphoma -- CYLD cylindromatosis -- DD deacetylase domain -- DMB dynein motor binding -- DNMT DNA methyltransferase -- EA ellagic acid -- EB end binding protein -- EC endothelial cell -- EGCG (−)-epigallocatechin-3-gallate -- EGFR epidermal growth factor receptor -- EMT epithelial-to-mesenchymal transition -- ER estrogen receptor -- ERK extracellular signal-regulated kinase -- ERST endoplasmic reticulum stress-tolerance -- FADD Fas-associated protein with death domain -- FDA Food and Drug Administration -- FLICE FADD-like IL-1 β-converting enzyme -- FLIP FLICE inhibitory protein -- GBM glioblastoma -- GR glucocorticoid receptor -- GSK glycogen synthase kinase -- HAT histone acetyltransferase -- HCC hepatocellular carcinoma -- HDAC histone deacetylase -- HDAC6i HDAC6 inhibitor -- HDACi HDAC inhibitor -- HIF hypoxia-inducible factor -- HMGN high mobility group nucleosomal binding domain -- HSF heat shock transcription factor -- HSP heat shock protein -- ICD immunogenic cell death -- IIp invasion inhibitory protein -- IL interleukin -- JAK Janus kinase -- LCoR ligand-dependent nuclear receptor co-repressor -- MAPK mitogen-activated protein kinase -- MM multiple myeloma -- MMP matrix metalloproteinase -- MST mammalian STE20-like kinase -- MT microtubule -- mTOR mammalian target of rapamycin -- NES nuclear export signal -- NLS nuclear localization signal -- Nrf nuclear factor erythroid 2-related factor -- PI3K phosphoinositide 3-kinase -- PKA protein kinase A -- PP protein phosphatase -- Prx peroxiredoxin -- PTEN phosphatase and tensin homolog -- PTM post-translational modification -- RhoB Ras homolog family member B -- RUNX runt-related transcription factor -- SAHA suberoylanilide hydroxamic acid -- SE14 cytoplasmic retention domain -- SFN sulforaphane -- SIRT sirtuin -- SMRT silencing mediator for retinoid or thyroid-hormone receptor -- SRSF serine and arginine rich splicing factor -- STAT signal transducer and activator of transcription -- Tau tubule-associated unit -- TGF transforming growth factor -- TPA 12-O-tetradecanoylphorbol-13-acetate -- TPPP tubulin polymerization-promoting protein -- TSA trichostatin A -- TSG tumor suppressor gene -- UA ursolic acid -- UDCA ursodeoxycholic acid -- VCP valosin-containing protein -- VEGF vascular endothelial growth factor -- VEGFR VEGF receptor -- ZBG zinc binding group 1
- FK228 (PubChem CID: 5352062) -- PXD101 (PubChem CID: 6918638) -- SAHA (PubChem CID: 5311) -- LBH-589 (PubChem CID: 6918837) -- tubacin (PubChem CID: 6675804) -- tubastatin A (PubChem CID: 49850262) -- ACY-1215 (PubChem CID: 53340666) -- ACY-241 (PubChem CID: 53340426) -- (−)-epigallocatechin-3-gallate (PubChem CID: 65064) -- aceroside VIII (PubChem CID: 21637600) -- curcumin (PubChem CID: 969516) -- ellagic acid (PubChem CID: 5281855) -- genistein (PubChem CID: 5280961) -- 20(S)-Rh2 (PubChem CID: 119307) -- salirepol (PubChem CID: 188287) -- butyrate (PubChem CID: 264) -- sulforaphane (PubChem CID: 5350) -- trichostatin A (PubChem CID: 444732) -- ursodeoxycholic acid (PubChem CID: 31401) -- ursolic acid (PubChem CID: 64945) 1
- HDAC6 -- HDAC6 inhibitors -- Natural compounds -- Cancer hallmarks -- Cancer therapy 1